Anavex Life Sciences Corp (AVXL)

[rocalinda]

"Unfortunately, we don't KNOW as much as many assume we know about 2-73, its MOA, or how many subjects are getting what dose."

You are right that we may not know as much as we would like to know at this point. That is why we have 3 trials under way which will answer many of such questions.

That said, we know that there has been extensive pre-clinical, and now 3 years of clinical, studies which indicate that the drug is safe and it achieves positive results in subjects with declining neurological health. That we know, and that is why many of us are choosing to continue to invest at this early stage of a very risky proposition.

It is advisable for those not with the appetite for such risk, to invest in safer financial instruments, which abound in the market place (CD's being some of the safest).

Good luck to you, whichever road you wish to travel.